nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—Bezafibrate—Glyburide—type 2 diabetes mellitus	0.17	1	CrCrCtD
Indomethacin—PPARA—type 2 diabetes mellitus	0.11	0.429	CbGaD
Indomethacin—PPARG—type 2 diabetes mellitus	0.0528	0.206	CbGaD
Indomethacin—ABCC2—type 2 diabetes mellitus	0.0515	0.201	CbGaD
Indomethacin—PPARG—Glipizide—type 2 diabetes mellitus	0.0318	0.0858	CbGbCtD
Indomethacin—PPARG—Repaglinide—type 2 diabetes mellitus	0.0278	0.075	CbGbCtD
Indomethacin—PPARG—Pioglitazone—type 2 diabetes mellitus	0.0252	0.0678	CbGbCtD
Indomethacin—PPARG—Rosiglitazone—type 2 diabetes mellitus	0.0232	0.0626	CbGbCtD
Indomethacin—PTGS2—type 2 diabetes mellitus	0.0223	0.0868	CbGaD
Indomethacin—ALB—type 2 diabetes mellitus	0.0199	0.0774	CbGaD
Indomethacin—PPARG—Nateglinide—type 2 diabetes mellitus	0.0191	0.0514	CbGbCtD
Indomethacin—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.0116	0.0312	CbGbCtD
Indomethacin—ABCC4—Nateglinide—type 2 diabetes mellitus	0.00968	0.0261	CbGbCtD
Indomethacin—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.00956	0.0258	CbGbCtD
Indomethacin—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.00865	0.0233	CbGbCtD
Indomethacin—ABCC3—Glyburide—type 2 diabetes mellitus	0.00856	0.0231	CbGbCtD
Indomethacin—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.00817	0.022	CbGbCtD
Indomethacin—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.00798	0.0215	CbGbCtD
Indomethacin—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.00705	0.019	CbGbCtD
Indomethacin—UGT2B7—Losartan—type 2 diabetes mellitus	0.00677	0.0182	CbGbCtD
Indomethacin—SLC22A7—Glyburide—type 2 diabetes mellitus	0.00669	0.018	CbGbCtD
Indomethacin—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.00634	0.0171	CbGbCtD
Indomethacin—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.00634	0.0171	CbGbCtD
Indomethacin—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.00585	0.0158	CbGbCtD
Indomethacin—UGT1A1—Losartan—type 2 diabetes mellitus	0.00585	0.0158	CbGbCtD
Indomethacin—ALB—Gliclazide—type 2 diabetes mellitus	0.00557	0.015	CbGbCtD
Indomethacin—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.00556	0.015	CbGbCtD
Indomethacin—ABCC1—Glyburide—type 2 diabetes mellitus	0.00525	0.0142	CbGbCtD
Indomethacin—ALB—Repaglinide—type 2 diabetes mellitus	0.00524	0.0141	CbGbCtD
Indomethacin—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.00496	0.0134	CbGbCtD
Indomethacin—PTGS1—Nateglinide—type 2 diabetes mellitus	0.00481	0.013	CbGbCtD
Indomethacin—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.00469	0.0126	CbGbCtD
Indomethacin—PTGS1—Irbesartan—type 2 diabetes mellitus	0.00461	0.0124	CbGbCtD
Indomethacin—ALB—Rosiglitazone—type 2 diabetes mellitus	0.00437	0.0118	CbGbCtD
Indomethacin—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.00421	0.0114	CbGbCtD
Indomethacin—SLCO1B1—Losartan—type 2 diabetes mellitus	0.00405	0.0109	CbGbCtD
Indomethacin—ABCC2—Glyburide—type 2 diabetes mellitus	0.00389	0.0105	CbGbCtD
Indomethacin—ALB—Valsartan—type 2 diabetes mellitus	0.00386	0.0104	CbGbCtD
Indomethacin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00384	0.0104	CbGbCtD
Indomethacin—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00361	0.00973	CbGbCtD
Indomethacin—ALB—Nateglinide—type 2 diabetes mellitus	0.00359	0.00967	CbGbCtD
Indomethacin—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00353	0.00952	CbGbCtD
Indomethacin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00343	0.00924	CbGbCtD
Indomethacin—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00323	0.0087	CbGbCtD
Indomethacin—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00307	0.00828	CbGbCtD
Indomethacin—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00307	0.00828	CbGbCtD
Indomethacin—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.003	0.00809	CbGbCtD
Indomethacin—SLC22A6—Glyburide—type 2 diabetes mellitus	0.00285	0.00767	CbGbCtD
Indomethacin—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00283	0.00764	CbGbCtD
Indomethacin—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00274	0.00738	CbGbCtD
Indomethacin—SLC22A6—Losartan—type 2 diabetes mellitus	0.0026	0.00702	CbGbCtD
Indomethacin—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00255	0.00688	CbGbCtD
Indomethacin—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00255	0.00688	CbGbCtD
Indomethacin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00248	0.00668	CbGbCtD
Indomethacin—ALB—Glyburide—type 2 diabetes mellitus	0.00242	0.00653	CbGbCtD
Indomethacin—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00236	0.00635	CbGbCtD
Indomethacin—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00227	0.00613	CbGbCtD
Indomethacin—ALB—Losartan—type 2 diabetes mellitus	0.00222	0.00598	CbGbCtD
Indomethacin—PPARA—brown adipose tissue—type 2 diabetes mellitus	0.00219	0.0631	CbGeAlD
Indomethacin—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00208	0.00561	CbGbCtD
Indomethacin—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00193	0.00521	CbGbCtD
Indomethacin—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00185	0.005	CbGbCtD
Indomethacin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0017	0.00459	CbGbCtD
Indomethacin—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00157	0.00424	CbGbCtD
Indomethacin—CYP2C19—Losartan—type 2 diabetes mellitus	0.00144	0.00387	CbGbCtD
Indomethacin—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00131	0.00352	CbGbCtD
Indomethacin—ABCB1—Glyburide—type 2 diabetes mellitus	0.00127	0.00342	CbGbCtD
Indomethacin—PPARG—brown adipose tissue—type 2 diabetes mellitus	0.0012	0.0347	CbGeAlD
Indomethacin—CYP2C9—Losartan—type 2 diabetes mellitus	0.00119	0.00322	CbGbCtD
Indomethacin—ABCB1—Losartan—type 2 diabetes mellitus	0.00116	0.00313	CbGbCtD
Indomethacin—PPARG—leg—type 2 diabetes mellitus	0.000967	0.0279	CbGeAlD
Indomethacin—Agomelatine—MTNR1A—type 2 diabetes mellitus	0.000902	0.304	CrCbGaD
Indomethacin—PPARG—hindlimb—type 2 diabetes mellitus	0.000864	0.0249	CbGeAlD
Indomethacin—PTGR2—cardiovascular system—type 2 diabetes mellitus	0.000624	0.018	CbGeAlD
Indomethacin—PTGR2—kidney—type 2 diabetes mellitus	0.00061	0.0176	CbGeAlD
Indomethacin—PTGR2—cortex of kidney—type 2 diabetes mellitus	0.000594	0.0172	CbGeAlD
Indomethacin—PTGR2—adipose tissue—type 2 diabetes mellitus	0.00055	0.0159	CbGeAlD
Indomethacin—GLO1—islet of Langerhans—type 2 diabetes mellitus	0.000533	0.0154	CbGeAlD
Indomethacin—PPARG—artery—type 2 diabetes mellitus	0.000529	0.0153	CbGeAlD
Indomethacin—PTGS2—leg—type 2 diabetes mellitus	0.000494	0.0143	CbGeAlD
Indomethacin—CXCL8—islet of Langerhans—type 2 diabetes mellitus	0.00049	0.0142	CbGeAlD
Indomethacin—Agomelatine—MTNR1B—type 2 diabetes mellitus	0.000474	0.16	CrCbGaD
Indomethacin—GLO1—retina—type 2 diabetes mellitus	0.000456	0.0132	CbGeAlD
Indomethacin—PPARG—endothelium—type 2 diabetes mellitus	0.000447	0.0129	CbGeAlD
Indomethacin—PTGS2—hindlimb—type 2 diabetes mellitus	0.000441	0.0127	CbGeAlD
Indomethacin—Fenofibrate—PPARA—type 2 diabetes mellitus	0.000431	0.145	CrCbGaD
Indomethacin—GLO1—nephron tubule—type 2 diabetes mellitus	0.000429	0.0124	CbGeAlD
Indomethacin—ABCC6—retina—type 2 diabetes mellitus	0.000419	0.0121	CbGeAlD
Indomethacin—PPARA—retina—type 2 diabetes mellitus	0.000396	0.0114	CbGeAlD
Indomethacin—CXCL8—nephron tubule—type 2 diabetes mellitus	0.000395	0.0114	CbGeAlD
Indomethacin—PTGR2—liver—type 2 diabetes mellitus	0.000386	0.0111	CbGeAlD
Indomethacin—GLO1—cardiovascular system—type 2 diabetes mellitus	0.000385	0.0111	CbGeAlD
Indomethacin—AKR1C3—islet of Langerhans—type 2 diabetes mellitus	0.000384	0.0111	CbGeAlD
Indomethacin—ABCC11—liver—type 2 diabetes mellitus	0.000382	0.011	CbGeAlD
Indomethacin—GLO1—kidney—type 2 diabetes mellitus	0.000377	0.0109	CbGeAlD
Indomethacin—GLO1—pancreas—type 2 diabetes mellitus	0.000375	0.0108	CbGeAlD
Indomethacin—GLO1—cortex of kidney—type 2 diabetes mellitus	0.000367	0.0106	CbGeAlD
Indomethacin—UGT1A9—kidney—type 2 diabetes mellitus	0.000366	0.0106	CbGeAlD
Indomethacin—PLA2G2A—cardiovascular system—type 2 diabetes mellitus	0.000358	0.0103	CbGeAlD
Indomethacin—ABCC6—cardiovascular system—type 2 diabetes mellitus	0.000355	0.0102	CbGeAlD
Indomethacin—PLA2G2A—kidney—type 2 diabetes mellitus	0.00035	0.0101	CbGeAlD
Indomethacin—PLA2G2A—pancreas—type 2 diabetes mellitus	0.000348	0.0101	CbGeAlD
Indomethacin—ABCC6—kidney—type 2 diabetes mellitus	0.000347	0.01	CbGeAlD
Indomethacin—CXCL8—pancreas—type 2 diabetes mellitus	0.000345	0.00995	CbGeAlD
Indomethacin—GLO1—adipose tissue—type 2 diabetes mellitus	0.00034	0.00981	CbGeAlD
Indomethacin—PPARA—cardiovascular system—type 2 diabetes mellitus	0.000335	0.00966	CbGeAlD
Indomethacin—PPARA—kidney—type 2 diabetes mellitus	0.000327	0.00946	CbGeAlD
Indomethacin—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.000327	0.00945	CbGeAlD
Indomethacin—PPARA—pancreas—type 2 diabetes mellitus	0.000325	0.00939	CbGeAlD
Indomethacin—PLA2G2A—adipose tissue—type 2 diabetes mellitus	0.000316	0.00912	CbGeAlD
Indomethacin—SLC10A1—kidney—type 2 diabetes mellitus	0.000315	0.00909	CbGeAlD
Indomethacin—ABCC6—adipose tissue—type 2 diabetes mellitus	0.000313	0.00903	CbGeAlD
Indomethacin—CXCL8—adipose tissue—type 2 diabetes mellitus	0.000313	0.00903	CbGeAlD
Indomethacin—AKR1C3—nephron tubule—type 2 diabetes mellitus	0.00031	0.00894	CbGeAlD
Indomethacin—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000308	0.0089	CbGeAlD
Indomethacin—PPARA—adipose tissue—type 2 diabetes mellitus	0.000295	0.00852	CbGeAlD
Indomethacin—UGT2B7—kidney—type 2 diabetes mellitus	0.000295	0.00852	CbGeAlD
Indomethacin—SLC22A11—kidney—type 2 diabetes mellitus	0.000287	0.0083	CbGeAlD
Indomethacin—PTGS1—artery—type 2 diabetes mellitus	0.000283	0.00817	CbGeAlD
Indomethacin—SLC22A7—kidney—type 2 diabetes mellitus	0.000281	0.0081	CbGeAlD
Indomethacin—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.00028	0.00809	CbGeAlD
Indomethacin—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.000273	0.00789	CbGeAlD
Indomethacin—PTGS2—artery—type 2 diabetes mellitus	0.000271	0.00781	CbGeAlD
Indomethacin—AKR1C3—pancreas—type 2 diabetes mellitus	0.00027	0.0078	CbGeAlD
Indomethacin—AKR1C3—cortex of kidney—type 2 diabetes mellitus	0.000265	0.00765	CbGeAlD
Indomethacin—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000264	0.00762	CbGeAlD
Indomethacin—PPARG—islet of Langerhans—type 2 diabetes mellitus	0.000254	0.00735	CbGeAlD
Indomethacin—UGT1A1—kidney—type 2 diabetes mellitus	0.000251	0.00724	CbGeAlD
Indomethacin—CES1—cardiovascular system—type 2 diabetes mellitus	0.000248	0.00717	CbGeAlD
Indomethacin—AKR1C3—adipose tissue—type 2 diabetes mellitus	0.000245	0.00708	CbGeAlD
Indomethacin—PTGS1—endothelium—type 2 diabetes mellitus	0.000239	0.00691	CbGeAlD
Indomethacin—GLO1—liver—type 2 diabetes mellitus	0.000238	0.00688	CbGeAlD
Indomethacin—UGT1A9—liver—type 2 diabetes mellitus	0.000231	0.00668	CbGeAlD
Indomethacin—PTGS2—endothelium—type 2 diabetes mellitus	0.000229	0.0066	CbGeAlD
Indomethacin—PLA2G2A—liver—type 2 diabetes mellitus	0.000222	0.0064	CbGeAlD
Indomethacin—Bezafibrate—HMGCR—type 2 diabetes mellitus	0.000221	0.0746	CrCbGaD
Indomethacin—ABCC6—liver—type 2 diabetes mellitus	0.000219	0.00633	CbGeAlD
Indomethacin—CXCL8—liver—type 2 diabetes mellitus	0.000219	0.00633	CbGeAlD
Indomethacin—CES1—adipose tissue—type 2 diabetes mellitus	0.000219	0.00632	CbGeAlD
Indomethacin—Bezafibrate—PPARA—type 2 diabetes mellitus	0.000218	0.0734	CrCbGaD
Indomethacin—SLCO1B1—kidney—type 2 diabetes mellitus	0.000209	0.00603	CbGeAlD
Indomethacin—PPARA—liver—type 2 diabetes mellitus	0.000207	0.00598	CbGeAlD
Indomethacin—SLC10A1—liver—type 2 diabetes mellitus	0.000199	0.00575	CbGeAlD
Indomethacin—ABCC3—kidney—type 2 diabetes mellitus	0.000198	0.00572	CbGeAlD
Indomethacin—UGT2B7—liver—type 2 diabetes mellitus	0.000186	0.00539	CbGeAlD
Indomethacin—ABCC4—nephron tubule—type 2 diabetes mellitus	0.000186	0.00537	CbGeAlD
Indomethacin—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000185	0.00533	CbGeAlD
Indomethacin—PPARG—cardiovascular system—type 2 diabetes mellitus	0.000184	0.00531	CbGeAlD
Indomethacin—SLC22A11—liver—type 2 diabetes mellitus	0.000182	0.00525	CbGeAlD
Indomethacin—ABCC2—nephron tubule—type 2 diabetes mellitus	0.00018	0.0052	CbGeAlD
Indomethacin—PPARG—kidney—type 2 diabetes mellitus	0.00018	0.0052	CbGeAlD
Indomethacin—PPARG—pancreas—type 2 diabetes mellitus	0.000179	0.00517	CbGeAlD
Indomethacin—ABCC3—adipose tissue—type 2 diabetes mellitus	0.000178	0.00515	CbGeAlD
Indomethacin—SLC22A7—liver—type 2 diabetes mellitus	0.000177	0.00512	CbGeAlD
Indomethacin—AKR1C3—liver—type 2 diabetes mellitus	0.000172	0.00497	CbGeAlD
Indomethacin—SLCO1A2—kidney—type 2 diabetes mellitus	0.00017	0.00491	CbGeAlD
Indomethacin—ABCC4—kidney—type 2 diabetes mellitus	0.000163	0.00472	CbGeAlD
Indomethacin—ABCC4—pancreas—type 2 diabetes mellitus	0.000162	0.00469	CbGeAlD
Indomethacin—PPARG—adipose tissue—type 2 diabetes mellitus	0.000162	0.00469	CbGeAlD
Indomethacin—SLC22A8—kidney—type 2 diabetes mellitus	0.000162	0.00468	CbGeAlD
Indomethacin—ABCC4—cortex of kidney—type 2 diabetes mellitus	0.000159	0.0046	CbGeAlD
Indomethacin—UGT1A1—liver—type 2 diabetes mellitus	0.000159	0.00458	CbGeAlD
Indomethacin—ABCC2—kidney—type 2 diabetes mellitus	0.000158	0.00457	CbGeAlD
Indomethacin—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000158	0.00456	CbGeAlD
Indomethacin—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000154	0.00445	CbGeAlD
Indomethacin—CES1—liver—type 2 diabetes mellitus	0.000154	0.00443	CbGeAlD
Indomethacin—ABCC4—adipose tissue—type 2 diabetes mellitus	0.000147	0.00426	CbGeAlD
Indomethacin—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.000136	0.00392	CbGeAlD
Indomethacin—SLCO1B1—liver—type 2 diabetes mellitus	0.000132	0.00381	CbGeAlD
Indomethacin—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.00013	0.00375	CbGeAlD
Indomethacin—ABCC1—adipose tissue—type 2 diabetes mellitus	0.000126	0.00363	CbGeAlD
Indomethacin—ABCC3—liver—type 2 diabetes mellitus	0.000125	0.00362	CbGeAlD
Indomethacin—Agomelatine—HTR2C—type 2 diabetes mellitus	0.000121	0.0408	CrCbGaD
Indomethacin—PPARG—liver—type 2 diabetes mellitus	0.000114	0.00329	CbGeAlD
Indomethacin—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000108	0.00311	CbGeAlD
Indomethacin—SLCO1A2—liver—type 2 diabetes mellitus	0.000107	0.0031	CbGeAlD
Indomethacin—ALB—liver—type 2 diabetes mellitus	0.000107	0.00308	CbGeAlD
Indomethacin—Bezafibrate—PPARG—type 2 diabetes mellitus	0.000104	0.0351	CrCbGaD
Indomethacin—ABCC4—liver—type 2 diabetes mellitus	0.000103	0.00298	CbGeAlD
Indomethacin—ABCC2—liver—type 2 diabetes mellitus	0.0001	0.00289	CbGeAlD
Indomethacin—PTGS1—cardiovascular system—type 2 diabetes mellitus	9.84e-05	0.00284	CbGeAlD
Indomethacin—PTGS1—kidney—type 2 diabetes mellitus	9.62e-05	0.00278	CbGeAlD
Indomethacin—PTGS2—cardiovascular system—type 2 diabetes mellitus	9.4e-05	0.00272	CbGeAlD
Indomethacin—PTGS2—kidney—type 2 diabetes mellitus	9.2e-05	0.00266	CbGeAlD
Indomethacin—PTGS2—pancreas—type 2 diabetes mellitus	9.14e-05	0.00264	CbGeAlD
Indomethacin—Agomelatine—CYP1A2—type 2 diabetes mellitus	9.14e-05	0.0308	CrCbGaD
Indomethacin—Fenofibrate—CYP3A4—type 2 diabetes mellitus	8.9e-05	0.03	CrCbGaD
Indomethacin—ABCC1—liver—type 2 diabetes mellitus	8.81e-05	0.00254	CbGeAlD
Indomethacin—PTGS1—adipose tissue—type 2 diabetes mellitus	8.67e-05	0.00251	CbGeAlD
Indomethacin—CYP2C19—liver—type 2 diabetes mellitus	8.59e-05	0.00248	CbGeAlD
Indomethacin—PTGS2—adipose tissue—type 2 diabetes mellitus	8.29e-05	0.00239	CbGeAlD
Indomethacin—ABCB1—islet of Langerhans—type 2 diabetes mellitus	8.04e-05	0.00232	CbGeAlD
Indomethacin—Bromfenac—PTGS2—type 2 diabetes mellitus	7.97e-05	0.0268	CrCbGaD
Indomethacin—ABCB1—retina—type 2 diabetes mellitus	6.88e-05	0.00199	CbGeAlD
Indomethacin—CYP2C9—liver—type 2 diabetes mellitus	6.66e-05	0.00192	CbGeAlD
Indomethacin—ABCB1—nephron tubule—type 2 diabetes mellitus	6.48e-05	0.00187	CbGeAlD
Indomethacin—Naproxen—CYP1A2—type 2 diabetes mellitus	6.22e-05	0.0209	CrCbGaD
Indomethacin—ABCB1—cardiovascular system—type 2 diabetes mellitus	5.82e-05	0.00168	CbGeAlD
Indomethacin—PTGS2—liver—type 2 diabetes mellitus	5.81e-05	0.00168	CbGeAlD
Indomethacin—ABCB1—kidney—type 2 diabetes mellitus	5.69e-05	0.00164	CbGeAlD
Indomethacin—ABCB1—pancreas—type 2 diabetes mellitus	5.65e-05	0.00163	CbGeAlD
Indomethacin—ABCB1—cortex of kidney—type 2 diabetes mellitus	5.54e-05	0.0016	CbGeAlD
Indomethacin—Tolmetin—PTGS2—type 2 diabetes mellitus	5.36e-05	0.018	CrCbGaD
Indomethacin—ABCB1—adipose tissue—type 2 diabetes mellitus	5.13e-05	0.00148	CbGeAlD
Indomethacin—Leukopenia—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000498	CcSEcCtD
Indomethacin—Discomfort—Metformin—type 2 diabetes mellitus	4.51e-05	0.000496	CcSEcCtD
Indomethacin—Fatigue—Gliclazide—type 2 diabetes mellitus	4.51e-05	0.000496	CcSEcCtD
Indomethacin—Bezafibrate—CYP3A4—type 2 diabetes mellitus	4.5e-05	0.0152	CrCbGaD
Indomethacin—Nausea—Glipizide—type 2 diabetes mellitus	4.49e-05	0.000494	CcSEcCtD
Indomethacin—Vomiting—Glimepiride—type 2 diabetes mellitus	4.49e-05	0.000494	CcSEcCtD
Indomethacin—Hypotension—Valsartan—type 2 diabetes mellitus	4.49e-05	0.000494	CcSEcCtD
Indomethacin—Vision blurred—Losartan—type 2 diabetes mellitus	4.48e-05	0.000493	CcSEcCtD
Indomethacin—Vomiting—Sitagliptin—type 2 diabetes mellitus	4.47e-05	0.000492	CcSEcCtD
Indomethacin—Constipation—Gliclazide—type 2 diabetes mellitus	4.47e-05	0.000492	CcSEcCtD
Indomethacin—Pain—Gliclazide—type 2 diabetes mellitus	4.47e-05	0.000492	CcSEcCtD
Indomethacin—Rash—Glimepiride—type 2 diabetes mellitus	4.45e-05	0.00049	CcSEcCtD
Indomethacin—Dermatitis—Glimepiride—type 2 diabetes mellitus	4.45e-05	0.000489	CcSEcCtD
Indomethacin—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	4.44e-05	0.000489	CcSEcCtD
Indomethacin—Rash—Sitagliptin—type 2 diabetes mellitus	4.44e-05	0.000488	CcSEcCtD
Indomethacin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	4.43e-05	0.000488	CcSEcCtD
Indomethacin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000488	CcSEcCtD
Indomethacin—Headache—Glimepiride—type 2 diabetes mellitus	4.42e-05	0.000486	CcSEcCtD
Indomethacin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	4.41e-05	0.000486	CcSEcCtD
Indomethacin—Headache—Sitagliptin—type 2 diabetes mellitus	4.41e-05	0.000485	CcSEcCtD
Indomethacin—Anaemia—Losartan—type 2 diabetes mellitus	4.4e-05	0.000484	CcSEcCtD
Indomethacin—Oedema—Metformin—type 2 diabetes mellitus	4.37e-05	0.000481	CcSEcCtD
Indomethacin—Tinnitus—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000481	CcSEcCtD
Indomethacin—Hypertension—Irbesartan—type 2 diabetes mellitus	4.37e-05	0.00048	CcSEcCtD
Indomethacin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	4.36e-05	0.000479	CcSEcCtD
Indomethacin—Flushing—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000479	CcSEcCtD
Indomethacin—Angioedema—Losartan—type 2 diabetes mellitus	4.35e-05	0.000478	CcSEcCtD
Indomethacin—Insomnia—Valsartan—type 2 diabetes mellitus	4.34e-05	0.000478	CcSEcCtD
Indomethacin—Paraesthesia—Valsartan—type 2 diabetes mellitus	4.31e-05	0.000474	CcSEcCtD
Indomethacin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	4.31e-05	0.000474	CcSEcCtD
Indomethacin—Chest pain—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000474	CcSEcCtD
Indomethacin—Shock—Metformin—type 2 diabetes mellitus	4.3e-05	0.000473	CcSEcCtD
Indomethacin—Insomnia—Orlistat—type 2 diabetes mellitus	4.29e-05	0.000472	CcSEcCtD
Indomethacin—Malaise—Losartan—type 2 diabetes mellitus	4.29e-05	0.000472	CcSEcCtD
Indomethacin—Anxiety—Irbesartan—type 2 diabetes mellitus	4.29e-05	0.000472	CcSEcCtD
Indomethacin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.29e-05	0.000472	CcSEcCtD
Indomethacin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.28e-05	0.000471	CcSEcCtD
Indomethacin—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.28e-05	0.000471	CcSEcCtD
Indomethacin—Vertigo—Losartan—type 2 diabetes mellitus	4.28e-05	0.00047	CcSEcCtD
Indomethacin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.27e-05	0.00047	CcSEcCtD
Indomethacin—Somnolence—Valsartan—type 2 diabetes mellitus	4.27e-05	0.00047	CcSEcCtD
Indomethacin—Syncope—Losartan—type 2 diabetes mellitus	4.27e-05	0.000469	CcSEcCtD
Indomethacin—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.26e-05	0.000469	CcSEcCtD
Indomethacin—Leukopenia—Losartan—type 2 diabetes mellitus	4.26e-05	0.000469	CcSEcCtD
Indomethacin—Discomfort—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000468	CcSEcCtD
Indomethacin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.23e-05	0.000465	CcSEcCtD
Indomethacin—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.23e-05	0.000465	CcSEcCtD
Indomethacin—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.21e-05	0.000463	CcSEcCtD
Indomethacin—Palpitations—Losartan—type 2 diabetes mellitus	4.2e-05	0.000463	CcSEcCtD
Indomethacin—Nausea—Glimepiride—type 2 diabetes mellitus	4.19e-05	0.000461	CcSEcCtD
Indomethacin—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000461	CcSEcCtD
Indomethacin—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.18e-05	0.00046	CcSEcCtD
Indomethacin—Nausea—Sitagliptin—type 2 diabetes mellitus	4.18e-05	0.00046	CcSEcCtD
Indomethacin—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.18e-05	0.00046	CcSEcCtD
Indomethacin—Asthenia—Glyburide—type 2 diabetes mellitus	4.18e-05	0.000459	CcSEcCtD
Indomethacin—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.17e-05	0.000459	CcSEcCtD
Indomethacin—Anorexia—Metformin—type 2 diabetes mellitus	4.17e-05	0.000459	CcSEcCtD
Indomethacin—Urticaria—Gliclazide—type 2 diabetes mellitus	4.15e-05	0.000457	CcSEcCtD
Indomethacin—Alopecia—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000456	CcSEcCtD
Indomethacin—Fatigue—Valsartan—type 2 diabetes mellitus	4.14e-05	0.000455	CcSEcCtD
Indomethacin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.13e-05	0.000455	CcSEcCtD
Indomethacin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.13e-05	0.000455	CcSEcCtD
Indomethacin—Oedema—Irbesartan—type 2 diabetes mellitus	4.13e-05	0.000454	CcSEcCtD
Indomethacin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.13e-05	0.000454	CcSEcCtD
Indomethacin—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.12e-05	0.000454	CcSEcCtD
Indomethacin—Pruritus—Glyburide—type 2 diabetes mellitus	4.12e-05	0.000453	CcSEcCtD
Indomethacin—Constipation—Valsartan—type 2 diabetes mellitus	4.11e-05	0.000452	CcSEcCtD
Indomethacin—Fatigue—Orlistat—type 2 diabetes mellitus	4.09e-05	0.00045	CcSEcCtD
Indomethacin—Hypotension—Metformin—type 2 diabetes mellitus	4.09e-05	0.00045	CcSEcCtD
Indomethacin—Erythema—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000449	CcSEcCtD
Indomethacin—Shock—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.000447	CcSEcCtD
Indomethacin—Pain—Orlistat—type 2 diabetes mellitus	4.06e-05	0.000446	CcSEcCtD
Indomethacin—Chest pain—Losartan—type 2 diabetes mellitus	4.05e-05	0.000446	CcSEcCtD
Indomethacin—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.05e-05	0.000445	CcSEcCtD
Indomethacin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.04e-05	0.000445	CcSEcCtD
Indomethacin—Anxiety—Losartan—type 2 diabetes mellitus	4.04e-05	0.000444	CcSEcCtD
Indomethacin—Naproxen—PTGS2—type 2 diabetes mellitus	4.03e-05	0.0136	CrCbGaD
Indomethacin—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.000443	CcSEcCtD
Indomethacin—Rash—Bromocriptine—type 2 diabetes mellitus	4.01e-05	0.000442	CcSEcCtD
Indomethacin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.01e-05	0.000441	CcSEcCtD
Indomethacin—Tension—Ramipril—type 2 diabetes mellitus	4e-05	0.00044	CcSEcCtD
Indomethacin—Discomfort—Losartan—type 2 diabetes mellitus	4e-05	0.00044	CcSEcCtD
Indomethacin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.99e-05	0.000439	CcSEcCtD
Indomethacin—Headache—Bromocriptine—type 2 diabetes mellitus	3.99e-05	0.000439	CcSEcCtD
Indomethacin—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.98e-05	0.000438	CcSEcCtD
Indomethacin—Nervousness—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000436	CcSEcCtD
Indomethacin—Anorexia—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000433	CcSEcCtD
Indomethacin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.93e-05	0.000432	CcSEcCtD
Indomethacin—Paraesthesia—Metformin—type 2 diabetes mellitus	3.93e-05	0.000432	CcSEcCtD
Indomethacin—Confusional state—Losartan—type 2 diabetes mellitus	3.92e-05	0.000431	CcSEcCtD
Indomethacin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.91e-05	0.00043	CcSEcCtD
Indomethacin—Dyspnoea—Metformin—type 2 diabetes mellitus	3.9e-05	0.000429	CcSEcCtD
Indomethacin—Somnolence—Metformin—type 2 diabetes mellitus	3.89e-05	0.000428	CcSEcCtD
Indomethacin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3.88e-05	0.000427	CcSEcCtD
Indomethacin—Oedema—Losartan—type 2 diabetes mellitus	3.88e-05	0.000427	CcSEcCtD
Indomethacin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.88e-05	0.000427	CcSEcCtD
Indomethacin—Hypotension—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.000424	CcSEcCtD
Indomethacin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.85e-05	0.000424	CcSEcCtD
Indomethacin—Dyspepsia—Metformin—type 2 diabetes mellitus	3.85e-05	0.000423	CcSEcCtD
Indomethacin—Shock—Losartan—type 2 diabetes mellitus	3.82e-05	0.00042	CcSEcCtD
Indomethacin—Urticaria—Valsartan—type 2 diabetes mellitus	3.81e-05	0.00042	CcSEcCtD
Indomethacin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.8e-05	0.000418	CcSEcCtD
Indomethacin—Decreased appetite—Metformin—type 2 diabetes mellitus	3.8e-05	0.000418	CcSEcCtD
Indomethacin—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.8e-05	0.000418	CcSEcCtD
Indomethacin—Tachycardia—Losartan—type 2 diabetes mellitus	3.79e-05	0.000417	CcSEcCtD
Indomethacin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000416	CcSEcCtD
Indomethacin—Nausea—Bromocriptine—type 2 diabetes mellitus	3.78e-05	0.000416	CcSEcCtD
Indomethacin—Fatigue—Metformin—type 2 diabetes mellitus	3.77e-05	0.000415	CcSEcCtD
Indomethacin—Urticaria—Orlistat—type 2 diabetes mellitus	3.77e-05	0.000415	CcSEcCtD
Indomethacin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.75e-05	0.000413	CcSEcCtD
Indomethacin—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.75e-05	0.000413	CcSEcCtD
Indomethacin—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.75e-05	0.000413	CcSEcCtD
Indomethacin—Asthenia—Gliclazide—type 2 diabetes mellitus	3.75e-05	0.000413	CcSEcCtD
Indomethacin—Constipation—Metformin—type 2 diabetes mellitus	3.74e-05	0.000411	CcSEcCtD
Indomethacin—Angioedema—Ramipril—type 2 diabetes mellitus	3.73e-05	0.00041	CcSEcCtD
Indomethacin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.71e-05	0.000408	CcSEcCtD
Indomethacin—Anorexia—Losartan—type 2 diabetes mellitus	3.7e-05	0.000407	CcSEcCtD
Indomethacin—Vomiting—Glyburide—type 2 diabetes mellitus	3.7e-05	0.000407	CcSEcCtD
Indomethacin—Pruritus—Gliclazide—type 2 diabetes mellitus	3.7e-05	0.000407	CcSEcCtD
Indomethacin—Malaise—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000405	CcSEcCtD
Indomethacin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.68e-05	0.000405	CcSEcCtD
Indomethacin—Rash—Glyburide—type 2 diabetes mellitus	3.67e-05	0.000404	CcSEcCtD
Indomethacin—Somnolence—Irbesartan—type 2 diabetes mellitus	3.67e-05	0.000404	CcSEcCtD
Indomethacin—Dermatitis—Glyburide—type 2 diabetes mellitus	3.67e-05	0.000403	CcSEcCtD
Indomethacin—Vertigo—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000403	CcSEcCtD
Indomethacin—Syncope—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000403	CcSEcCtD
Indomethacin—Leukopenia—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000402	CcSEcCtD
Indomethacin—Headache—Glyburide—type 2 diabetes mellitus	3.65e-05	0.000401	CcSEcCtD
Indomethacin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.63e-05	0.0004	CcSEcCtD
Indomethacin—Hypotension—Losartan—type 2 diabetes mellitus	3.63e-05	0.000399	CcSEcCtD
Indomethacin—Palpitations—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000397	CcSEcCtD
Indomethacin—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.6e-05	0.000396	CcSEcCtD
Indomethacin—ABCB1—liver—type 2 diabetes mellitus	3.6e-05	0.00104	CbGeAlD
Indomethacin—Naproxen—ALB—type 2 diabetes mellitus	3.59e-05	0.0121	CrCbGaD
Indomethacin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.59e-05	0.000395	CcSEcCtD
Indomethacin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.59e-05	0.000395	CcSEcCtD
Indomethacin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.58e-05	0.000393	CcSEcCtD
Indomethacin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.58e-05	0.000393	CcSEcCtD
Indomethacin—Fatigue—Irbesartan—type 2 diabetes mellitus	3.56e-05	0.000391	CcSEcCtD
Indomethacin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.54e-05	0.000389	CcSEcCtD
Indomethacin—Convulsion—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000389	CcSEcCtD
Indomethacin—Pain—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.000388	CcSEcCtD
Indomethacin—Constipation—Irbesartan—type 2 diabetes mellitus	3.53e-05	0.000388	CcSEcCtD
Indomethacin—Insomnia—Losartan—type 2 diabetes mellitus	3.51e-05	0.000386	CcSEcCtD
Indomethacin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.5e-05	0.000385	CcSEcCtD
Indomethacin—Paraesthesia—Losartan—type 2 diabetes mellitus	3.49e-05	0.000384	CcSEcCtD
Indomethacin—Urticaria—Metformin—type 2 diabetes mellitus	3.47e-05	0.000382	CcSEcCtD
Indomethacin—Chest pain—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000382	CcSEcCtD
Indomethacin—Dyspnoea—Losartan—type 2 diabetes mellitus	3.46e-05	0.000381	CcSEcCtD
Indomethacin—Anxiety—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000381	CcSEcCtD
Indomethacin—Nausea—Glyburide—type 2 diabetes mellitus	3.46e-05	0.00038	CcSEcCtD
Indomethacin—Abdominal pain—Metformin—type 2 diabetes mellitus	3.46e-05	0.00038	CcSEcCtD
Indomethacin—Dizziness—Gliclazide—type 2 diabetes mellitus	3.46e-05	0.00038	CcSEcCtD
Indomethacin—Somnolence—Losartan—type 2 diabetes mellitus	3.45e-05	0.00038	CcSEcCtD
Indomethacin—Asthenia—Valsartan—type 2 diabetes mellitus	3.45e-05	0.000379	CcSEcCtD
Indomethacin—Discomfort—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000378	CcSEcCtD
Indomethacin—Dyspepsia—Losartan—type 2 diabetes mellitus	3.42e-05	0.000376	CcSEcCtD
Indomethacin—Asthenia—Orlistat—type 2 diabetes mellitus	3.4e-05	0.000375	CcSEcCtD
Indomethacin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.4e-05	0.000374	CcSEcCtD
Indomethacin—Pruritus—Valsartan—type 2 diabetes mellitus	3.4e-05	0.000374	CcSEcCtD
Indomethacin—Decreased appetite—Losartan—type 2 diabetes mellitus	3.38e-05	0.000371	CcSEcCtD
Indomethacin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.000371	CcSEcCtD
Indomethacin—Confusional state—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000369	CcSEcCtD
Indomethacin—Pruritus—Orlistat—type 2 diabetes mellitus	3.36e-05	0.000369	CcSEcCtD
Indomethacin—Fatigue—Losartan—type 2 diabetes mellitus	3.35e-05	0.000368	CcSEcCtD
Indomethacin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000366	CcSEcCtD
Indomethacin—Oedema—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000366	CcSEcCtD
Indomethacin—Vomiting—Gliclazide—type 2 diabetes mellitus	3.32e-05	0.000366	CcSEcCtD
Indomethacin—Pain—Losartan—type 2 diabetes mellitus	3.32e-05	0.000365	CcSEcCtD
Indomethacin—Constipation—Losartan—type 2 diabetes mellitus	3.32e-05	0.000365	CcSEcCtD
Indomethacin—Rash—Gliclazide—type 2 diabetes mellitus	3.3e-05	0.000363	CcSEcCtD
Indomethacin—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.29e-05	0.000362	CcSEcCtD
Indomethacin—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.29e-05	0.000361	CcSEcCtD
Indomethacin—Urticaria—Irbesartan—type 2 diabetes mellitus	3.28e-05	0.000361	CcSEcCtD
Indomethacin—Shock—Ramipril—type 2 diabetes mellitus	3.28e-05	0.00036	CcSEcCtD
Indomethacin—Headache—Gliclazide—type 2 diabetes mellitus	3.27e-05	0.00036	CcSEcCtD
Indomethacin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.26e-05	0.000359	CcSEcCtD
Indomethacin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.26e-05	0.000359	CcSEcCtD
Indomethacin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000359	CcSEcCtD
Indomethacin—Tachycardia—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000358	CcSEcCtD
Indomethacin—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.25e-05	0.000357	CcSEcCtD
Indomethacin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000354	CcSEcCtD
Indomethacin—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.2e-05	0.000352	CcSEcCtD
Indomethacin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.18e-05	0.000349	CcSEcCtD
Indomethacin—Dizziness—Valsartan—type 2 diabetes mellitus	3.18e-05	0.000349	CcSEcCtD
Indomethacin—Anorexia—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000349	CcSEcCtD
Indomethacin—Dizziness—Orlistat—type 2 diabetes mellitus	3.14e-05	0.000345	CcSEcCtD
Indomethacin—Asthenia—Metformin—type 2 diabetes mellitus	3.14e-05	0.000345	CcSEcCtD
Indomethacin—Hypotension—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000342	CcSEcCtD
Indomethacin—Nausea—Gliclazide—type 2 diabetes mellitus	3.1e-05	0.000342	CcSEcCtD
Indomethacin—Pruritus—Metformin—type 2 diabetes mellitus	3.09e-05	0.00034	CcSEcCtD
Indomethacin—Urticaria—Losartan—type 2 diabetes mellitus	3.09e-05	0.000339	CcSEcCtD
Indomethacin—Body temperature increased—Losartan—type 2 diabetes mellitus	3.07e-05	0.000338	CcSEcCtD
Indomethacin—Abdominal pain—Losartan—type 2 diabetes mellitus	3.07e-05	0.000338	CcSEcCtD
Indomethacin—Vomiting—Valsartan—type 2 diabetes mellitus	3.05e-05	0.000336	CcSEcCtD
Indomethacin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.04e-05	0.000334	CcSEcCtD
Indomethacin—Rash—Valsartan—type 2 diabetes mellitus	3.03e-05	0.000333	CcSEcCtD
Indomethacin—Dermatitis—Valsartan—type 2 diabetes mellitus	3.02e-05	0.000333	CcSEcCtD
Indomethacin—Vomiting—Orlistat—type 2 diabetes mellitus	3.02e-05	0.000332	CcSEcCtD
Indomethacin—Insomnia—Ramipril—type 2 diabetes mellitus	3.01e-05	0.000331	CcSEcCtD
Indomethacin—Headache—Valsartan—type 2 diabetes mellitus	3.01e-05	0.000331	CcSEcCtD
Indomethacin—Diarrhoea—Metformin—type 2 diabetes mellitus	2.99e-05	0.000329	CcSEcCtD
Indomethacin—Rash—Orlistat—type 2 diabetes mellitus	2.99e-05	0.000329	CcSEcCtD
Indomethacin—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.99e-05	0.000329	CcSEcCtD
Indomethacin—Dermatitis—Orlistat—type 2 diabetes mellitus	2.99e-05	0.000329	CcSEcCtD
Indomethacin—Headache—Orlistat—type 2 diabetes mellitus	2.97e-05	0.000327	CcSEcCtD
Indomethacin—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000327	CcSEcCtD
Indomethacin—Asthenia—Irbesartan—type 2 diabetes mellitus	2.96e-05	0.000326	CcSEcCtD
Indomethacin—Somnolence—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000326	CcSEcCtD
Indomethacin—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000322	CcSEcCtD
Indomethacin—Pruritus—Irbesartan—type 2 diabetes mellitus	2.92e-05	0.000321	CcSEcCtD
Indomethacin—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.89e-05	0.000318	CcSEcCtD
Indomethacin—Dizziness—Metformin—type 2 diabetes mellitus	2.89e-05	0.000318	CcSEcCtD
Indomethacin—Fatigue—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000316	CcSEcCtD
Indomethacin—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.86e-05	0.000315	CcSEcCtD
Indomethacin—Nausea—Valsartan—type 2 diabetes mellitus	2.85e-05	0.000314	CcSEcCtD
Indomethacin—Constipation—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000313	CcSEcCtD
Indomethacin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.82e-05	0.000311	CcSEcCtD
Indomethacin—Nausea—Orlistat—type 2 diabetes mellitus	2.82e-05	0.00031	CcSEcCtD
Indomethacin—Asthenia—Losartan—type 2 diabetes mellitus	2.79e-05	0.000307	CcSEcCtD
Indomethacin—Vomiting—Metformin—type 2 diabetes mellitus	2.78e-05	0.000306	CcSEcCtD
Indomethacin—Rash—Metformin—type 2 diabetes mellitus	2.76e-05	0.000303	CcSEcCtD
Indomethacin—Dermatitis—Metformin—type 2 diabetes mellitus	2.75e-05	0.000303	CcSEcCtD
Indomethacin—Pruritus—Losartan—type 2 diabetes mellitus	2.75e-05	0.000302	CcSEcCtD
Indomethacin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000302	CcSEcCtD
Indomethacin—Headache—Metformin—type 2 diabetes mellitus	2.74e-05	0.000301	CcSEcCtD
Indomethacin—Dizziness—Irbesartan—type 2 diabetes mellitus	2.73e-05	0.0003	CcSEcCtD
Indomethacin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.72e-05	0.0003	CcSEcCtD
Indomethacin—Diarrhoea—Losartan—type 2 diabetes mellitus	2.66e-05	0.000292	CcSEcCtD
Indomethacin—Urticaria—Ramipril—type 2 diabetes mellitus	2.65e-05	0.000291	CcSEcCtD
Indomethacin—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.63e-05	0.00029	CcSEcCtD
Indomethacin—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.63e-05	0.00029	CcSEcCtD
Indomethacin—Vomiting—Irbesartan—type 2 diabetes mellitus	2.62e-05	0.000289	CcSEcCtD
Indomethacin—Rash—Irbesartan—type 2 diabetes mellitus	2.6e-05	0.000286	CcSEcCtD
Indomethacin—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.6e-05	0.000286	CcSEcCtD
Indomethacin—Nausea—Metformin—type 2 diabetes mellitus	2.6e-05	0.000286	CcSEcCtD
Indomethacin—Headache—Irbesartan—type 2 diabetes mellitus	2.59e-05	0.000284	CcSEcCtD
Indomethacin—Dizziness—Losartan—type 2 diabetes mellitus	2.57e-05	0.000283	CcSEcCtD
Indomethacin—Vomiting—Losartan—type 2 diabetes mellitus	2.47e-05	0.000272	CcSEcCtD
Indomethacin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.45e-05	0.00027	CcSEcCtD
Indomethacin—Nausea—Irbesartan—type 2 diabetes mellitus	2.45e-05	0.00027	CcSEcCtD
Indomethacin—Rash—Losartan—type 2 diabetes mellitus	2.45e-05	0.000269	CcSEcCtD
Indomethacin—Dermatitis—Losartan—type 2 diabetes mellitus	2.45e-05	0.000269	CcSEcCtD
Indomethacin—Headache—Losartan—type 2 diabetes mellitus	2.43e-05	0.000268	CcSEcCtD
Indomethacin—Asthenia—Ramipril—type 2 diabetes mellitus	2.39e-05	0.000263	CcSEcCtD
Indomethacin—Pruritus—Ramipril—type 2 diabetes mellitus	2.36e-05	0.000259	CcSEcCtD
Indomethacin—Nausea—Losartan—type 2 diabetes mellitus	2.31e-05	0.000254	CcSEcCtD
Indomethacin—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.28e-05	0.000251	CcSEcCtD
Indomethacin—Dizziness—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000242	CcSEcCtD
Indomethacin—Vomiting—Ramipril—type 2 diabetes mellitus	2.12e-05	0.000233	CcSEcCtD
Indomethacin—Rash—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000231	CcSEcCtD
Indomethacin—Dermatitis—Ramipril—type 2 diabetes mellitus	2.1e-05	0.000231	CcSEcCtD
Indomethacin—Headache—Ramipril—type 2 diabetes mellitus	2.09e-05	0.00023	CcSEcCtD
Indomethacin—Nausea—Ramipril—type 2 diabetes mellitus	1.98e-05	0.000218	CcSEcCtD
Indomethacin—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	1.14e-06	1.54e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—INS—type 2 diabetes mellitus	1.14e-06	1.54e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	1.13e-06	1.53e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.13e-06	1.53e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	1.13e-06	1.52e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.12e-06	1.51e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	1.12e-06	1.51e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	1.12e-06	1.51e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.12e-06	1.51e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	1.11e-06	1.5e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.11e-06	1.5e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.11e-06	1.5e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.11e-06	1.5e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.11e-06	1.5e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.11e-06	1.5e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.11e-06	1.5e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	1.11e-06	1.5e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	1.1e-06	1.49e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—type 2 diabetes mellitus	1.1e-06	1.49e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GCG—type 2 diabetes mellitus	1.1e-06	1.49e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	1.1e-06	1.49e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.1e-06	1.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	1.09e-06	1.48e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.09e-06	1.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IRS2—type 2 diabetes mellitus	1.09e-06	1.47e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.09e-06	1.47e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	1.09e-06	1.47e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	1.09e-06	1.47e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.09e-06	1.47e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	1.08e-06	1.46e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—type 2 diabetes mellitus	1.08e-06	1.46e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—type 2 diabetes mellitus	1.08e-06	1.46e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	1.08e-06	1.46e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.08e-06	1.46e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.08e-06	1.46e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.07e-06	1.45e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CALM1—type 2 diabetes mellitus	1.07e-06	1.45e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOE—type 2 diabetes mellitus	1.07e-06	1.44e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	1.07e-06	1.44e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—type 2 diabetes mellitus	1.06e-06	1.44e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.06e-06	1.43e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.06e-06	1.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOA1—type 2 diabetes mellitus	1.06e-06	1.43e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.05e-06	1.42e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	1.04e-06	1.41e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	1.04e-06	1.41e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	1.04e-06	1.41e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.04e-06	1.41e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	1.04e-06	1.41e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.04e-06	1.4e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.04e-06	1.4e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.04e-06	1.4e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—type 2 diabetes mellitus	1.04e-06	1.4e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.04e-06	1.4e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.04e-06	1.4e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.04e-06	1.4e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—NOS3—type 2 diabetes mellitus	1.04e-06	1.4e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	1.03e-06	1.39e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	1.03e-06	1.39e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.03e-06	1.39e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.02e-06	1.38e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.02e-06	1.37e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.02e-06	1.37e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.01e-06	1.37e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	1.01e-06	1.37e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.01e-06	1.36e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.01e-06	1.36e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.01e-06	1.36e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	1e-06	1.36e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	1e-06	1.35e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.99e-07	1.35e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	9.98e-07	1.35e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.98e-07	1.35e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.96e-07	1.35e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.95e-07	1.34e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS2—type 2 diabetes mellitus	9.95e-07	1.34e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—type 2 diabetes mellitus	9.94e-07	1.34e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	9.92e-07	1.34e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SRC—type 2 diabetes mellitus	9.89e-07	1.34e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	9.89e-07	1.34e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	9.88e-07	1.33e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	9.88e-07	1.33e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	9.81e-07	1.33e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.8e-07	1.32e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.64e-07	1.3e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	9.64e-07	1.3e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	9.63e-07	1.3e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—INS—type 2 diabetes mellitus	9.62e-07	1.3e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	9.61e-07	1.3e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IRS1—type 2 diabetes mellitus	9.53e-07	1.29e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	9.5e-07	1.28e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	9.49e-07	1.28e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.49e-07	1.28e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GNB3—type 2 diabetes mellitus	9.48e-07	1.28e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.48e-07	1.28e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	9.47e-07	1.28e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	9.47e-07	1.28e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SRC—type 2 diabetes mellitus	9.46e-07	1.28e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	9.44e-07	1.27e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	9.42e-07	1.27e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	9.39e-07	1.27e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	9.39e-07	1.27e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAT—type 2 diabetes mellitus	9.31e-07	1.26e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.21e-07	1.24e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	9.16e-07	1.24e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	9.13e-07	1.23e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	9.13e-07	1.23e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—INS—type 2 diabetes mellitus	9.12e-07	1.23e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.11e-07	1.23e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOB—type 2 diabetes mellitus	9.04e-07	1.22e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	9e-07	1.22e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	9e-07	1.22e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	8.97e-07	1.21e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	8.94e-07	1.21e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—type 2 diabetes mellitus	8.91e-07	1.2e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	8.84e-07	1.19e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	8.84e-07	1.19e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	8.82e-07	1.19e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT2—type 2 diabetes mellitus	8.82e-07	1.19e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SRC—type 2 diabetes mellitus	8.82e-07	1.19e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	8.79e-07	1.19e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	8.68e-07	1.17e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—LPL—type 2 diabetes mellitus	8.63e-07	1.17e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.51e-07	1.15e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	8.51e-07	1.15e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	8.47e-07	1.14e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.46e-07	1.14e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	8.45e-07	1.14e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	8.44e-07	1.14e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.44e-07	1.14e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GPX1—type 2 diabetes mellitus	8.42e-07	1.14e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	8.38e-07	1.13e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	8.36e-07	1.13e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	8.31e-07	1.12e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.31e-07	1.12e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.29e-07	1.12e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	8.27e-07	1.12e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CD36—type 2 diabetes mellitus	8.2e-07	1.11e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	8.16e-07	1.1e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	8.12e-07	1.1e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	8.1e-07	1.09e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—type 2 diabetes mellitus	8.08e-07	1.09e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS3—type 2 diabetes mellitus	8e-07	1.08e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	8e-07	1.08e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	7.92e-07	1.07e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	7.89e-07	1.07e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	7.88e-07	1.06e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	7.79e-07	1.05e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	7.77e-07	1.05e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.76e-07	1.05e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	7.76e-07	1.05e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	7.75e-07	1.05e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—type 2 diabetes mellitus	7.73e-07	1.04e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—type 2 diabetes mellitus	7.73e-07	1.04e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	7.73e-07	1.04e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	7.72e-07	1.04e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	7.71e-07	1.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—INS—type 2 diabetes mellitus	7.64e-07	1.03e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARA—type 2 diabetes mellitus	7.62e-07	1.03e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	7.62e-07	1.03e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	7.59e-07	1.02e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	7.56e-07	1.02e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	7.56e-07	1.02e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.45e-07	1.01e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	7.4e-07	1e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	7.4e-07	1e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AGT—type 2 diabetes mellitus	7.38e-07	9.98e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	7.38e-07	9.97e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	7.36e-07	9.95e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	7.27e-07	9.82e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CALM1—type 2 diabetes mellitus	7.26e-07	9.81e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOE—type 2 diabetes mellitus	7.24e-07	9.77e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	7.2e-07	9.72e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	7.19e-07	9.71e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOA1—type 2 diabetes mellitus	7.15e-07	9.66e-06	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—type 2 diabetes mellitus	7.12e-07	9.62e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	7.1e-07	9.59e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	7.07e-07	9.54e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	7e-07	9.46e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	6.98e-07	9.42e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	6.92e-07	9.34e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	6.89e-07	9.31e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	6.84e-07	9.25e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	6.81e-07	9.2e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	6.71e-07	9.07e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	6.7e-07	9.05e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.7e-07	9.05e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	6.68e-07	9.02e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	6.63e-07	8.96e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	6.63e-07	8.96e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	6.52e-07	8.81e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	6.5e-07	8.77e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	6.47e-07	8.74e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	6.42e-07	8.67e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—type 2 diabetes mellitus	6.37e-07	8.61e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	6.36e-07	8.59e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	6.36e-07	8.59e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	6.34e-07	8.56e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—type 2 diabetes mellitus	6.3e-07	8.51e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	6.27e-07	8.47e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	6.24e-07	8.43e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—INS—type 2 diabetes mellitus	6.18e-07	8.35e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	6.15e-07	8.3e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.04e-07	8.17e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	5.94e-07	8.03e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—type 2 diabetes mellitus	5.94e-07	8.02e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	5.92e-07	8e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SRC—type 2 diabetes mellitus	5.92e-07	7.99e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.88e-07	7.94e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—type 2 diabetes mellitus	5.86e-07	7.91e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	5.86e-07	7.91e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	5.85e-07	7.91e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	5.66e-07	7.64e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	5.55e-07	7.5e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—type 2 diabetes mellitus	5.54e-07	7.48e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	5.52e-07	7.46e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—type 2 diabetes mellitus	5.48e-07	7.4e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	5.42e-07	7.32e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NOS3—type 2 diabetes mellitus	5.42e-07	7.32e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—INS—type 2 diabetes mellitus	5.42e-07	7.32e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	5.29e-07	7.15e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—type 2 diabetes mellitus	5.19e-07	7.01e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.16e-07	6.97e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.1e-07	6.89e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	5.09e-07	6.87e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.06e-07	6.83e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	4.97e-07	6.71e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	4.96e-07	6.7e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	4.87e-07	6.57e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	4.87e-07	6.57e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	4.76e-07	6.43e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	4.76e-07	6.43e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	4.75e-07	6.42e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.75e-07	6.42e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	4.64e-07	6.27e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	4.59e-07	6.2e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	4.45e-07	6.01e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.44e-07	5.99e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.44e-07	5.99e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	4.36e-07	5.89e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.34e-07	5.87e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.06e-07	5.48e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—type 2 diabetes mellitus	3.99e-07	5.39e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	3.88e-07	5.24e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—type 2 diabetes mellitus	3.68e-07	4.97e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	3.08e-07	4.16e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—type 2 diabetes mellitus	2.49e-07	3.37e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	2.24e-07	3.02e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.18e-07	2.95e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.04e-07	2.76e-06	CbGpPWpGaD
